Cas 955992-89-9,2-(4-methoxyphenyl)-N-(4-methylbenzyl)-N-(1-cyclobutylpiperidin-4-yl)acetamide oxalate

955992-89-9

Post Buying Request

Basic information

Product Name: 2-(4-methoxyphenyl)-N-(4-methylbenzyl)-N-(1-cyclobutylpiperidin-4-yl)acetamide oxalate
Synonyms: 2-(4-methoxyphenyl)-N-(4-methylbenzyl)-N-(1-cyclobutylpiperidin-4-yl)acetamide oxalate
CAS NO:955992-89-9
Molecular Formula:
Molecular Weight: 496.604
EINECS: N/A
Product Categories: N/A
Mol File: 955992-89-9.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 2-(4-methoxyphenyl)-N-(4-methylbenzyl)-N-(1-cyclobutylpiperidin-4-yl)acetamide oxalate(CAS DataBase Reference)
NIST Chemistry Reference: 2-(4-methoxyphenyl)-N-(4-methylbenzyl)-N-(1-cyclobutylpiperidin-4-yl)acetamide oxalate(955992-89-9)
EPA Substance Registry System: 2-(4-methoxyphenyl)-N-(4-methylbenzyl)-N-(1-cyclobutylpiperidin-4-yl)acetamide oxalate(955992-89-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 955992-89-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

955992-89-9 Suppliers

Recommended suppliersmore

955992-89-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 955992-89-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,5,9,9 and 2 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 955992-89:
(8*9)+(7*5)+(6*5)+(5*9)+(4*9)+(3*2)+(2*8)+(1*9)=249
249 % 10 = 9
So 955992-89-9 is a valid CAS Registry Number.

955992-89-9Upstream product

955992-89-9Downstream Products

955992-89-9Relevant articles and documents

USE OF 4-AMINO-PIPERIDINES FOR TREATING SLEEP DISORDERS

-

Page/Page column 137-138, (2010/11/28)

Inverse agonists and antagonists of serotonin receptors are disclosed for use in treating sleep disorders such as insomnia, and specifically sleep maintenance insomnia. The compound increase slow wave sleep, decrease the number of awakenings after sleep onset, and decrease the time awake after sleep onset.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 955992-89-9